Drug Science publishes peer reviewed research, reports, and articles to provide clear, evidence-based information without political or commercial interference.

In this update, find out what GPs think about medical cannabis as we celebrate 1000 patients joining Project Twenty21. We share updates on the project, including new clinics and data insights, as well as initiatives working to improve medical cannabis in the UK. We also announce new events related to the…

In this update, we reveal a new clinical analysis of epilepsy T21 epilepsy patients and share the latest data and patient stories from Project Twenty21. We also announce new events related to the project and medical cannabis more generally. Learn more about Project Twenty21 Over the past month, we’ve been working…

YouGov poll results on psilocybin therapy and the government decision to reschedule psilocybin

Summary Full Report Survey Data Does the UK support psilocybin research?Public perceptions of psilocybin-assisted therapy have been revealed in a new YouGov poll, commissioned by Drug Science. This is the first nationally representative poll of UK attitudes towards the medicalisation of psilocybin and support for policy changes (such as rescheduling psilocybin)…

Knowledge about the therapeutic potential of medical cannabis has greatly improved over the past decade, with an ever-increasing range of developments in human clinical applications. A growing body of scientific evidence supports the use of medical cannabis products for some therapeutic indications, but for others, the evidence base remains disputed. One…

In this update, we reveal the first paper to be published from Project Twenty21! We also share the latest data and patient experiences, as well as a video showing what it's like to be a prescriber with Project Twenty21. We also announce new events related to the project and medical cannabis…